|
MysolineDrug - Mysoline The trade name of the product as shown on the labeling.
Dosage -
SUSPENSION; ORAL
Active Ingredient(s) -
Primidone
Strength -
250MG/5ML
Applicant -
XCEL PHARMS
New Drug Application (NDA) Number -
010401
Product Number -
001
Therapeutic Equivalence (TE) Code -
Approval Date -
Approved Prior to Jan 1, 1982
Reference Listed Drug (RLD) -
No
Type -
DISCN
Applicant Full Name -
Xcel Pharmaceuticals
Mysoline
Mysoline 250mg/5ml Suspension; Oral
Lyrica 300mg Capsule; Oral Lyrica 50mg Capsule; Oral Lyrica 75mg Capsule; Oral Citanest 1% Injectable; Injection Citanest 2% Injectable; Injection Citanest 3% Injectable; Injection Citanest Plain 4% Injectable; Injection Citanest Plain 4% Injectable; Injection Primaquine Eq 15mg Base Tablet; Oral NewDrugInformation |